We use cookies for a better user experience. Click here to know more about it. 


Global Closed System Drug Transfer Device (CSTD) Market Potential With CAGR 19% - QYResearch Report

Author: QYResearch  |   Published Date: 2021-04-14   |   Views: 93

A closed system drug transfer device or "CSTD" is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system.

The global Closed System Drug Transfer Device (CSTD) market was US$ 627.03 million in 2020 and is expected to US$ 2.12 billion by the end of 2027, growing at a CAGR of 19.00% between 2021 and 2027.

How can healthcare professionals protect their health when working with hazardous drugs? This is a key challenge when delivering treatment to patients. Many hazardous drugs are frequently used in patient treatment protocols. They can include antineoplastic drugs for chemotherapy, antibiotics and new monoclonal antibodies. These drugs, while saving patient lives, can also damage the health of healthcare professionals. This can happen if the drugs leak during compounding, reconstitution or administration to patients.

Healthcare professionals, including pharmacists, nurses and veterinarians, can be exposed to hazardous drug through inhalation, skin contact, accidental hand-to-mouth ingestion or needle stick and sharps injuries. Also, if these drugs leak in handling, they are a health risk to other healthcare workers, patients, patient families and the environment.

NIOSH has defined a Closed System Drug-Transfer Device (CSTD) as “a drug transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of the hazardous drug or vapor concentrations outside the system”.

The NIOSH definition covers two design types: CSTDs that work by means of a physical barrier, and CSTDs that use air-cleaning technology. Both design types prevent the release of hazardous drugs into the healthcare workplace. Occupational exposure while compounding and administering hazardous drugs is linked to a range of negative health consequences. CSTDs that meet the NIOSH definition,  protect healthcare professionals against such exposure.


Global Closed System Drug Transfer Device (CSTD) Market- Key Players

BD Medical, Inc., Equashield, ICU Medical, Teva Medical Ltd, Corvida Medical, B. Braun are some of the key players, functioning in the global Closed System Drug Transfer Device (CSTD) market. The industry is highly concentrated due to the high technology barrier. Presently, BD Medical is the largest supplier in the market with more than 43% share.


Millions of healthcare workers are exposed to chemotherapy and other hazardous drugs annually. Studies have shown that exposure to these hazardous drugs can cause serious health problems, “such as cancer, reproductive and development problems and other adverse effects that can be irreversible even after low-level exposures,” according to the Occupational Safety & Health Administration (OSHA), National Institute of Occupational Safety & Health (NIOSH), and Joint Commission. Therefore, Potential market is huge in the future.

United States dominated the Closed System Drug Transfer Device (CSTD), and is the largest production base. In addition to United States, there are some other production areas, such as Europe. In consumption market, North America is the mainly consumption regions due to the bigger demand of downstream applications. In 2020, North America occupied 79.33% of the global revenue in total. However, the above forecast is based on the current policy. If a country suddenly made the relevant policies, then the entire market will change.


Read More Information: https://www.qyresearch.com/index/detail/3040080/global-closed-system-drug-transfer-device-cstd-market


About Us:

QYResearch provides Market Research Reports for clients all over the world. As of now, QYResearch data as following:

62000 + Clients(cover 100% the world strong 500 companies and most industries’ leading players such as TOP5 players)

7800 + Experts(most of them with more than 15 years’ experience in their industry and professional knowledge both in market and technology)

300 + Data Base(40% government related data base, 30% third part data base, 10% international agencies data base, 30% technology and market data base)

2 Million + Reports(cover almost all industries and most detailed products such as product model level research reports, where you can find all what you need in one shop)

1000 + Custom Research Projects(most clients need custom research service and QYResearch keeps offering good and depth service for them)

30 + Roles Data Interview Checking System(only QYResearch uses such interview system with more than 30 roles in order to confirm the data reliability)

13 + Years focus market research and continues to support the client success.


Media Contact:

Rahul Singh - Digital Marketing Director

Contact: +91 7028 920 828   +81-903-800-9273    +86-108-294-5717

Email: rahul@qyresearch.com

Sales Contact US:

USA Registered Office: QY Research, INC.

17890 Castleton, Suite 369,

City of industry, CA - 91748

Phone: +1-626-295-2442

Emails – enquiry@qyrsearch.com

Web – www.qyresearch.com

QYR Clients

  • csl
  • croozer
  • crital alert
  • cristal
  • corveneng
  • coperion
  • contijpi medical
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
More Clients...